Enhanced Detection System for Healthcare-Associated Transmission of Infection
增强型医疗相关感染传播检测系统
基本信息
- 批准号:10297306
- 负责人:
- 金额:$ 77.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-26 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAdultAlgorithmsAreaCenters for Disease Control and Prevention (U.S.)ChildhoodClinicalClinical DataClinical MicrobiologyCollectionComplexComputing MethodologiesDataDatabasesDetectionDevelopmentDisease OutbreaksEconomic ModelsEconomicsElectronic Health RecordEpidemiologyEvaluationGenesGeneticGenomeGenomicsGoalsHealth Care CostsHealthcareHealthcare SystemsHospital CostsHospitalizationHospitalsIncidenceInfectionInfection preventionInfectious Disease EpidemiologyInfluenzaInterruptionInvestigationLaboratoriesLeadLinkMachine LearningMethodsMinisatellite RepeatsMobile Genetic ElementsModelingMorbidity - disease ratePatientsPoliciesPrevalencePreventionPrevention programResearchResidual stateResourcesRespiratory syncytial virusRouteSamplingSeasonsSingle Nucleotide PolymorphismSpecimenSyntenyTestingTimeValidationViralViral Respiratory Tract InfectionVirusacute careadjudicateadvanced analyticsanalytical methodanalytical toolbacterial genome sequencingbasebudget impactdata miningdetection platformeconomic evaluationevidence basegenome sequencinggenomic epidemiologyhealth care settingshealthcare-associated infectionsimprovedinnovationmicrobial genomicsmortalityneglectnovelnovel strategiespathogenpatient safetypreventprospectiverespiratoryrespiratory infection virusrespiratory virussoundsuccesssurveillance datatransmission processviral transmissionwastingwhole genome
项目摘要
Project Summary
Despite recent progress in reducing the incidence of healthcare-associated infections (HAIs), the Centers for
Disease Control and Prevention estimated that 687,000 HAIs occurred in U.S. acute care hospitals in 2015
and that the HAI prevalence on a given day was one in 30 patients. An estimated 72,000 patients died with
HAIs during their hospitalization. In addition, outbreaks in hospitals remain a serious problem but the vast
majority of hospitals use antiquated and ineffective methods to detect them. We established the Enhanced
Detection System for Healthcare Acquired Transmission (EDS-HAT) (R01AI127472), which combines bacterial
whole genome sequencing (WGS) surveillance (as opposed to reactive WGS) to detect outbreaks with data
mining (DM) of the electronic health record (EHR) and machine learning (ML) to identify the responsible
transmission routes. We have demonstrated that EDS-HAT detects both serious outbreaks that were otherwise
unrecognized and novel transmission routes. Despite this success, additional research is needed to improve
upon EDS-HAT and further increase capacity to detect and interrupt hospital outbreaks. For example, hospital
outbreaks of respiratory viruses such as influenza and SARS-CoV-2 are well documented, but this area of
infection prevention is understudied. The addition of respiratory virus surveillance to EDS-HAT would improve
detection and prevention of these costly HAIs. In addition, readily-available clinical microbiology data can be
incorporated into EDS-HAT algorithms to reduce reliance on WGS surveillance. Finally, WGS surveillance
analysis based entirely on core single nucleotide polymorphisms (SNPs) can falsely cluster patients.
Therefore, research to investigate the contribution(s) of the accessory genome is necessary to improve
discriminatory power of EDS-HAT. In this R01 renewal application, we propose to leverage the success of
EDS-HAT by developing additional innovative methods for identification and interruption of hospital-associated
transmission. In aim 1, we plan to use WGS surveillance and EHR DM/ML to study hospital transmission of
respiratory viruses from retrospective (aim 1a) and prospective collections (aim 1b) of respiratory virus positive
specimens at two large academic hospitals (EDS-HAT RV), one for adults and the other pediatric. In aim 2, we
will develop advanced analytic methods to create a version of EDS-HAT that relies primarily on DM/ML of the
EHR (EDS-HAT Lite) (aim 2a) and improve the discriminatory power of WGS to correctly classify patients who
are part of an outbreak (aim 2b). EDS-HAT RV and EDS-HAT Lite will undergo clinical and budget impact
analyses to determine the number of cases prevented and healthcare costs averted. These aims will be
accomplished by a team with expertise in infectious diseases epidemiology, outbreak investigation, infection
prevention, microbial genomics and genomic epidemiology, machine learning and data mining, and economic
analysis and modeling. Our proposed research will lead to improved patient safety and can serve as a model
for how outbreaks are detected and interrupted in hospitals.
项目概要
尽管最近在降低医疗保健相关感染 (HAI) 发生率方面取得了进展,但中心
美国疾病控制与预防中心估计,2015 年美国急症护理医院发生了 687,000 例 HAI
并且某一天的 HAI 患病率为 30 名患者中就有 1 人。估计有 72,000 名患者死于
住院期间发生 HAI。此外,医院内的疫情暴发仍然是一个严重的问题,但
大多数医院使用陈旧且无效的方法来检测它们。我们建立了增强型
医疗保健获得性传播检测系统 (EDS-HAT) (R01AI127472),结合了细菌
全基因组测序 (WGS) 监测(与反应性 WGS 相对)通过数据检测疫情
电子健康记录 (EHR) 的挖掘 (DM) 和机器学习 (ML) 来识别责任人
传播途径。我们已经证明 EDS-HAT 可以检测到两种严重的疫情
未被识别的新颖的传播途径。尽管取得了这一成功,但仍需要进行更多研究来改进
基于 EDS-HAT 并进一步提高检测和中断医院疫情的能力。例如,医院
流感和 SARS-CoV-2 等呼吸道病毒的爆发已有充分记录,但这一领域
感染预防尚未得到充分研究。 EDS-HAT 中增加呼吸道病毒监测将改善
检测和预防这些代价高昂的 HAI。此外,可以随时获得临床微生物学数据
纳入 EDS-HAT 算法以减少对 WGS 监测的依赖。最后,WGS 监测
完全基于核心单核苷酸多态性 (SNP) 的分析可能会错误地对患者进行聚类。
因此,有必要研究辅助基因组的贡献,以改善
EDS-HAT 的歧视力。在此 R01 续订申请中,我们建议利用以下方面的成功
EDS-HAT 通过开发额外的创新方法来识别和中断医院相关的
传播。在目标 1 中,我们计划使用 WGS 监测和 EHR DM/ML 来研究医院传播
来自呼吸道病毒阳性的回顾性(目标 1a)和前瞻性收集(目标 1b)的呼吸道病毒
标本来自两家大型学术医院 (EDS-HAT RV),一家用于成人,另一家用于儿童。在目标 2 中,我们
将开发先进的分析方法来创建主要依赖于 DM/ML 的 EDS-HAT 版本
EHR (EDS-HAT Lite)(目标 2a)并提高 WGS 的区分能力,以正确分类患者
是疫情爆发的一部分(目标 2b)。 EDS-HAT RV 和 EDS-HAT Lite 将受到临床和预算影响
进行分析以确定预防的病例数量和避免的医疗费用。这些目标将是
由在传染病流行病学、疫情调查、感染方面具有专业知识的团队完成
预防、微生物基因组学和基因组流行病学、机器学习和数据挖掘以及经济
分析和建模。我们提出的研究将提高患者的安全性,并可以作为一个模型
了解如何在医院发现和阻止疫情爆发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lee H Harrison其他文献
The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor—Active Surveillance in Selected Sites, United States, 2014–2017
美国念珠菌血症流行病学的变化:注射毒品使用作为日益常见的危险因素——美国选定地点的主动监测,2014-2017 年
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
Y. Zhang;S. Shrum;Sabrina R. Williams;Sarah Petnic;Joelle Nadle;Helen L. Johnston;Devra M. Barter;B. Vonbank;Lindsay Bonner;R. Hollick;Kaytlynn Marceaux;Lee H Harrison;William Schaffner;B. Tesini;M. Farley;A. Pierce;Erin C. Phipps;K. Mody;M. Chiller;R. Jackson;S. Vallabhaneni - 通讯作者:
S. Vallabhaneni
Lee H Harrison的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lee H Harrison', 18)}}的其他基金
Tracking plasmid spread and transmission in the hospital: A novel tool for infection prevention and control
追踪医院内的质粒传播和传播:感染预防和控制的新工具
- 批准号:
10721660 - 财政年份:2023
- 资助金额:
$ 77.76万 - 项目类别:
Pitt-Mozambique Training Program(Pitt-MozHRTP) in COVID-19, Cardiovascular Disease, and Diabetes in People with HIV
皮特-莫桑比克 COVID-19、心血管疾病和艾滋病毒感染者糖尿病培训计划 (Pitt-MozHRTP)
- 批准号:
10614598 - 财政年份:2022
- 资助金额:
$ 77.76万 - 项目类别:
Pitt-Mozambique Training Program(Pitt-MozHRTP) in COVID-19, Cardiovascular Disease, and Diabetes in People with HIV
皮特-莫桑比克 COVID-19、心血管疾病和艾滋病毒感染者糖尿病培训计划 (Pitt-MozHRTP)
- 批准号:
10471504 - 财政年份:2022
- 资助金额:
$ 77.76万 - 项目类别:
University of Pittsburgh Training Program in Antimicrobial Resistance
匹兹堡大学抗菌素耐药性培训计划
- 批准号:
10371067 - 财政年份:2019
- 资助金额:
$ 77.76万 - 项目类别:
South Africa-Pittsburgh Public Health Genomic Epidemiology Research Training Program (SAPPHGenE)
南非-匹兹堡公共卫生基因组流行病学研究培训计划 (SAPPHGenE)
- 批准号:
10329934 - 财政年份:2019
- 资助金额:
$ 77.76万 - 项目类别:
University of Pittsburgh Training Program in Antimicrobial Resistance
匹兹堡大学抗菌素耐药性培训计划
- 批准号:
10590645 - 财政年份:2019
- 资助金额:
$ 77.76万 - 项目类别:
South Africa-Pittsburgh Public Health Genomic Epidemiology Research Training Program (SAPPHGenE)
南非-匹兹堡公共卫生基因组流行病学研究培训计划 (SAPPHGenE)
- 批准号:
10551302 - 财政年份:2019
- 资助金额:
$ 77.76万 - 项目类别:
South Africa-Pittsburgh Public Health Genomic Epidemiology Research Training Program (SAPPHGenE)
南非-匹兹堡公共卫生基因组流行病学研究培训计划 (SAPPHGenE)
- 批准号:
9904390 - 财政年份:2019
- 资助金额:
$ 77.76万 - 项目类别:
University of Pittsburgh Training Program in Antimicrobial Resistance
匹兹堡大学抗菌素耐药性培训计划
- 批准号:
10117170 - 财政年份:2019
- 资助金额:
$ 77.76万 - 项目类别:
University of Pittsburgh Training Program in Antimicrobial Resistance
匹兹堡大学抗菌素耐药性培训计划
- 批准号:
9788691 - 财政年份:2019
- 资助金额:
$ 77.76万 - 项目类别:
相似国自然基金
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Leveraging Pathogen-Host Networks to Identify Virus-specific and Estradiol-regulated Mechanisms during Respiratory Infection
利用病原体宿主网络来识别呼吸道感染期间的病毒特异性和雌二醇调节机制
- 批准号:
10741119 - 财政年份:2023
- 资助金额:
$ 77.76万 - 项目类别:
Identification of Risk Factors for predicting outcomes of COVID-19-Related Multisystem Inflammatory Syndrome in Children (MISC) using Real World Clinical Data
使用真实世界临床数据识别预测 COVID-19 相关儿童多系统炎症综合征 (MISC) 结果的风险因素
- 批准号:
10527735 - 财政年份:2022
- 资助金额:
$ 77.76万 - 项目类别:
Identification of Risk Factors for predicting outcomes of COVID-19-Related Multisystem Inflammatory Syndrome in Children (MISC) using Real World Clinical Data
使用真实世界临床数据识别预测 COVID-19 相关儿童多系统炎症综合征 (MISC) 结果的风险因素
- 批准号:
10679093 - 财政年份:2022
- 资助金额:
$ 77.76万 - 项目类别:
Systems biological assessment of T cell responses to vaccination
T 细胞对疫苗接种反应的系统生物学评估
- 批准号:
10584571 - 财政年份:2022
- 资助金额:
$ 77.76万 - 项目类别:
Immunologic and Predictive Features of MIS-C
MIS-C 的免疫学和预测特征
- 批准号:
10667530 - 财政年份:2022
- 资助金额:
$ 77.76万 - 项目类别: